FDA APPROVES OF A NEW NASAL SPARY GIMOTI

FDA APPROVES OF A NEW NASAL SPRAY GIMOTI

Highlights:

• The new nasal spray will be useful in relieving patents of diabetic gastroparesis

• The commercial launch shall be in Q4 2020

Evoke Pharma Inc’s nasal spray GIMOTI is now approved by the Food and Drug Administration, USA. This was announced by the company on Friday via SEC filing.

GIMOTI is a nas....